ANI Pharmaceuticals ANIP Payments to Acquire Intangible Assets
Payments to Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's payments to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's payments to acquire intangible assets?
- ANI Pharmaceuticals (ANIP) reported payments to acquire intangible assets of $5.25M in Q1 2026.
- How has ANI Pharmaceuticals's payments to acquire intangible assets changed year-over-year?
- ANI Pharmaceuticals's payments to acquire intangible assets decreased by 69.8% year-over-year, from $17.37M to $5.25M.
- What is the long-term trend for ANI Pharmaceuticals's payments to acquire intangible assets?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's payments to acquire intangible assets has grown at a -0.7% compound annual growth rate (CAGR), from $21.08M to $20.49M.